• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳洛酮索赔与独立药店和连锁药店比例之间的关联:美国纳洛酮索赔的纵向分析。

The association between naloxone claims and proportion of independent versus chain pharmacies: A longitudinal analysis of naloxone claims in the United States.

出版信息

J Am Pharm Assoc (2003). 2024 Jul-Aug;64(4):102093. doi: 10.1016/j.japh.2024.102093. Epub 2024 Apr 10.

DOI:10.1016/j.japh.2024.102093
PMID:38604474
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11402586/
Abstract

BACKGROUND

Expanding access to naloxone through pharmacies is an important policy goal. Our objective was to characterize national county-level naloxone dispensing of chain versus independent pharmacies.

METHODS

The primary exposure in our longitudinal analysis was the proportion of chain pharmacies in a county, identified through the U.S. Department of Homeland Security 2010 Infrastructure Foundation-Level Data. We defined counties as having "higher proportion" of chain pharmacies if at least 50% of pharmacies were large national chains. The primary outcome was quarter-year (2016Q1-2019Q2) rate of pharmacy naloxone claims per 100,000 persons from Symphony Health at the county level. We compared the naloxone dispensing rate between county types using 2-sample t tests. We estimated the association between county-level chain pharmacy proportion and rate of naloxone claims using a linear model with year-quarter fixed effects.

RESULTS

Nearly one-third of counties (n = 946) were higher proportion. Higher proportion counties had a significantly higher rate of naloxone claims across the study period, in 4 of 6 urban-rural classifications, and in counties with and without naloxone access laws (NALs). The linear model confirmed that higher proportion counties had a significantly higher rate of naloxone claims, adjusting for urban-rural designation, income, population characteristics, opioid mortality rate, coprescribing laws, and NALs.

CONCLUSION

In this national study, we found an association between naloxone dispensing rates and the county-level proportion of chain (vs. independent) pharmacies. Incentivizing naloxone dispensing through educational, regulatory, or legal efforts may improve naloxone availability and dispensing rates-particularly in counties with proportionately high numbers of independent pharmacies.

摘要

背景

通过药店扩大纳洛酮的获取途径是一个重要的政策目标。我们的目标是描述全国县级连锁药店和独立药店的纳洛酮配药情况。

方法

在我们的纵向分析中,主要暴露因素是一个县的连锁药店比例,通过美国国土安全部 2010 年基础设施基础数据确定。我们将至少 50%的药店为大型全国连锁店的县定义为“连锁药店比例较高”。主要结果是每个县每季度(2016 年第一季度至 2019 年第二季度)从 Symphony Health 获得的药店纳洛酮配药率,以每 10 万人为单位。我们使用 2 样本 t 检验比较了不同县类型的纳洛酮配药率。我们使用具有年季度固定效应的线性模型,估计了县级连锁药店比例与纳洛酮配药率之间的关联。

结果

近三分之一的县(n=946)属于连锁药店比例较高的县。在整个研究期间,在 6 个城乡分类中的 4 个,以及在有和没有纳洛酮获取法(NAL)的县中,连锁药店比例较高的县的纳洛酮配药率都显著较高。线性模型证实,在调整了城乡指定、收入、人口特征、阿片类药物死亡率、共同处方法和 NAL 后,连锁药店比例较高的县的纳洛酮配药率显著较高。

结论

在这项全国性研究中,我们发现纳洛酮配药率与县级连锁(与独立)药店比例之间存在关联。通过教育、监管或法律手段激励纳洛酮配药,可能会提高纳洛酮的可及性和配药率,特别是在独立药店比例较高的县。

相似文献

1
The association between naloxone claims and proportion of independent versus chain pharmacies: A longitudinal analysis of naloxone claims in the United States.纳洛酮索赔与独立药店和连锁药店比例之间的关联:美国纳洛酮索赔的纵向分析。
J Am Pharm Assoc (2003). 2024 Jul-Aug;64(4):102093. doi: 10.1016/j.japh.2024.102093. Epub 2024 Apr 10.
2
Implementation of Medication Disposal Programs and Availability of Same-Day Naloxone at Community Pharmacies: Protocol for a Secret Shopper Caller Approach.社区药房药物处置计划的实施及同日纳洛酮的可及性:秘密购物者致电法方案
JMIR Res Protoc. 2025 Jun 10;14:e64344. doi: 10.2196/64344.
3
Naloxone accessibility without an outside prescription from U.S. community pharmacies: A systematic review.美国社区药店无需处方即可获得纳洛酮:系统评价。
J Am Pharm Assoc (2003). 2022 Nov-Dec;62(6):1725-1740. doi: 10.1016/j.japh.2022.07.008. Epub 2022 Jul 31.
4
Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care.用于癌症患者和接受姑息治疗患者的阿片类药物引起的肠道功能障碍的μ-阿片受体拮抗剂。
Cochrane Database Syst Rev. 2018 Jun 5;6(6):CD006332. doi: 10.1002/14651858.CD006332.pub3.
5
Interventions to reduce non-prescription antimicrobial sales in community pharmacies.减少社区药房非处方抗菌药物销售的干预措施。
Cochrane Database Syst Rev. 2025 Jan 29;1(1):CD013722. doi: 10.1002/14651858.CD013722.pub2.
6
Pharmacists' naloxone services beyond community pharmacy settings: A systematic review.社区药房环境以外的药剂师纳洛酮服务:一项系统综述。
Res Social Adm Pharm. 2023 Feb;19(2):243-265. doi: 10.1016/j.sapharm.2022.09.002. Epub 2022 Sep 15.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
Do heroin overdose patients require observation after receiving naloxone?海洛因过量患者在接受纳洛酮治疗后需要观察吗?
Clin Toxicol (Phila). 2017 Feb;55(2):81-87. doi: 10.1080/15563650.2016.1253846. Epub 2016 Nov 16.
9
Opioid antagonists with minimal sedation for opioid withdrawal.用于阿片类药物戒断且镇静作用极小的阿片类拮抗剂。
Cochrane Database Syst Rev. 2017 May 29;5(5):CD002021. doi: 10.1002/14651858.CD002021.pub4.
10
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.暴力死亡监测——2022年全国暴力死亡报告系统,50个州、哥伦比亚特区和波多黎各
MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1.

引用本文的文献

1
Transforming Opioid Overdose Prevention in the United States: Leveraging FDA's Narcan Approval to Foster a Culture of Health.转变美国阿片类药物过量预防:利用美国食品药品监督管理局对纳洛酮的批准来培育健康文化。
Risk Manag Healthc Policy. 2025 Jun 14;18:1935-1946. doi: 10.2147/RMHP.S521720. eCollection 2025.
2
Naloxone training programs in corporately-owned versus independently-owned Alabama community pharmacies: A pilot cross-sectional survey.阿拉巴马州公司所有与独立经营的社区药房中的纳洛酮培训项目:一项试点横断面调查
Drug Alcohol Depend Rep. 2025 Mar 28;15:100326. doi: 10.1016/j.dadr.2025.100326. eCollection 2025 Jun.

本文引用的文献

1
The role of increasing pharmacy and community distributed naloxone in the opioid overdose epidemic in Massachusetts, Rhode Island, and New York City.增加药房和社区分发纳洛酮在马萨诸塞州、罗德岛州及纽约市阿片类药物过量流行问题中的作用。
Drug Alcohol Depend Rep. 2022 Sep;4. doi: 10.1016/j.dadr.2022.100083. Epub 2022 Jul 27.
2
A Systematic Review of Independent and Chain Pharmacies Effects on Medication Adherence.独立药店和连锁药店对药物依从性影响的系统评价
Pharmacy (Basel). 2022 Sep 29;10(5):124. doi: 10.3390/pharmacy10050124.
3
Access to community pharmacies: A nationwide geographic information systems cross-sectional analysis.
社区药房可及性:全国性地理信息系统横断面分析。
J Am Pharm Assoc (2003). 2022 Nov-Dec;62(6):1816-1822.e2. doi: 10.1016/j.japh.2022.07.003. Epub 2022 Jul 15.
4
Trends in State-Level Pharmacy-Based Naloxone Dispensing Rates, 2012-2019.2012-2019 年各州级基于药房的纳洛酮配药率趋势。
Am J Prev Med. 2021 Dec;61(6):e289-e295. doi: 10.1016/j.amepre.2021.05.042. Epub 2021 Oct 18.
5
Analysis of naloxone access and primary medication nonadherence in a community pharmacy setting.在社区药房环境中分析纳洛酮的可及性和主要药物不依从性。
J Am Pharm Assoc (2003). 2022 Jan-Feb;62(1):49-54. doi: 10.1016/j.japh.2021.10.011. Epub 2021 Oct 21.
6
State laws that authorize pharmacists to prescribe naloxone are associated with increased naloxone dispensing in retail pharmacies.州法律授权药剂师开纳洛酮处方与零售药店纳洛酮配药的增加有关。
Drug Alcohol Depend. 2021 Oct 1;227:109012. doi: 10.1016/j.drugalcdep.2021.109012. Epub 2021 Aug 28.
7
Naloxone availability in independent community pharmacies in Georgia, 2019.2019 年佐治亚州独立社区药店纳洛酮的可获得性。
Subst Abuse Treat Prev Policy. 2021 Aug 21;16(1):63. doi: 10.1186/s13011-021-00402-w.
8
Implications of county-level variation in U.S. opioid distribution.美国阿片类药物配送的县级差异所产生的影响。
Drug Alcohol Depend. 2021 Feb 1;219:108501. doi: 10.1016/j.drugalcdep.2020.108501. Epub 2021 Jan 3.
9
Point-of-sale Naloxone: Novel Community-based Research to Identify Naloxone Availability.售点纳洛酮:基于社区的新型研究以确定纳洛酮的可获得性。
West J Emerg Med. 2020 Aug 24;21(5):1188-1194. doi: 10.5811/westjem.7.2020.47252.
10
Availability of Naloxone at Rural Georgia Pharmacies, 2019.2019年佐治亚州农村地区药店纳洛酮的可获得情况。
JAMA Netw Open. 2020 Feb 5;3(2):e1921227. doi: 10.1001/jamanetworkopen.2019.21227.